NewsBenzingaAndersen Group、5件の新たな買収契約に署名し、2026年のM&A取引総額は約2億2,800万ドルに到達。契約には、インドのDOT1 Solutions、米国の1 Rivet、インドの1 Rivet、スペインのBraintrust、Andersen Polandが含まれ、年間換算売上高は3,810万ドル増加。 Andersen Group、5件の新たな買収契約に署名し、2026年のM&A取引総額は約2億2,800万ドルに到達。契約には、インドのDOT1 Solutions、米国の1 Rivet、インドの1 Rivet、スペインのBraintrust、Andersen Polandが含まれ、年間換算売上高は3,810万ドル増加。 Benzinga 2026.11.10 20:05 (GMT+0) Open on Benzinga Other news 'China Taps US AI Models To Train Homegrown Rivals As Chip Curbs Bite' - Reuters Exclusive 'US Presses UN Agency Over Taiwan Flight Restrictions, China Hits Back' - Reuters Exclusive 'Ruined The System'? Pete Buttigieg Pushes Back On Trump's FAA Blame, Demands Accounting for Billions In Modernization Funds After 'Worst FAA Communications Breakdown This Century' Reported Earlier, NextNRG Q3 EPS $(6.88) Misses $(6.00) Estimate, Sales $26.715M Miss $28.087M Estimate Reported Earlier, Lecanemab Five-Year Clarity AD Data: 36% Lower Relative Risk Of Disease-Stage Progression Vs. ADNI, 62% Of Low-Tau Patients Improved On CDR-SB, Consistent Safety Profile, Per Eisai And Biogen Aytu BioPharma Stock Climbs 44% After-Hours: Here's Why
'Ruined The System'? Pete Buttigieg Pushes Back On Trump's FAA Blame, Demands Accounting for Billions In Modernization Funds After 'Worst FAA Communications Breakdown This Century'
Reported Earlier, NextNRG Q3 EPS $(6.88) Misses $(6.00) Estimate, Sales $26.715M Miss $28.087M Estimate
Reported Earlier, Lecanemab Five-Year Clarity AD Data: 36% Lower Relative Risk Of Disease-Stage Progression Vs. ADNI, 62% Of Low-Tau Patients Improved On CDR-SB, Consistent Safety Profile, Per Eisai And Biogen